Trials / Active Not Recruiting
Active Not RecruitingNCT05150561
Muscle Dysfunction in Patients With Haematological Diseases
The Prevalence and the Prognostic Value of Sarcopenia Among Patients With Haematological Cancer Diseases - A Prospective Observational Cohort Study.
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 216 (estimated)
- Sponsor
- Rigshospitalet, Denmark · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
PURPOSE: To evaluate the prevalence and prognostic value of sarcopenia in patients diagnosed with hematological cancer diseases.
Detailed description
Some patients diagnosed with malignant hematological diseases are faced with poor prognosis and thus must undergo a demanding course of treatment associated with severe deconditioning potentially leading to worse prognostic outcomes. It is currently not well-described, to what extend patients body composition at the point of diagnoses should be part of standard clinical evaluation in order to optimize therapy-efficacy. Recent findings suggest that pathophysiological alterations in skeletal muscle mass and function can have significant implications for the risk of disease progression and long-term prognosis.
Conditions
Timeline
- Start date
- 2023-10-01
- Primary completion
- 2025-10-30
- Completion
- 2026-05-01
- First posted
- 2021-12-09
- Last updated
- 2025-08-11
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT05150561. Inclusion in this directory is not an endorsement.